Skip to main content
. Author manuscript; available in PMC: 2010 Aug 23.
Published in final edited form as: Nature. 2009 Apr 28;459(7246):569–573. doi: 10.1038/nature07953

Table 1.

CNVs in gene regions previously implicated in ASDs

Gene/region Region of significance Type Validation ACC
case
ACC
control
AGRE
case
AGRE
control
Inh Combined
P value
Permuted
P value
UBE3A 15q11–13 chr15: 21200234–26208861 Dup MLPA, qPCR 8 0 7 (5) 0 6:0:2 (75%) 1 × 10−5 <0.001
NRXN1 chr2: 51120644–51147600 Del qPCR 4 0 6 (4) 0 4:3:0 (100%) 4.7 × 10−4 0.002
CNTN4 chr3: 1915190–1915922 Del qPCR 3 0 7 (4) 0 5:3:0 (100%) 4.7 × 10−4 0.004
22q11.21 chr22: 19351264–19358946 Dup MLPA 5 0 4 0 2:4:0 (100%) 0.0010 0.008
CNTN4 chr3: 2548148–2548531 Dup qPCR 1 1 8 (6) 0 2:3:1 (83%) 0.0078 0.013
16p11.2 chr16: 29554844–30085308 Dup Affymetrix 2 3 7 (3) 1 3:4:1 (88%) 0.162 0.408
16p11.2 chr16: 29554844–30085308 Del Affymetrix 3 2 5 (4) 2 0:0:5 (0%) 0.246 0.300
AUTS2 chr7: 68576554–68967283 Dup Affymetrix 0 0 1 0 1:0:0 (100%) 0.466 0.425
NLGN3 chrX: 70288980–70460080 Dup Affymetrix 0 0 1 1 0:0:0 (NA) 0.601 0.601
SHANK3 chr22: 49456858–49524956 Del Affymetrix 2 1 0 1 4:3:0 (100%) 1 1

The number in parenthesis refers to count of unrelated siblings or distinct unrelated families. The sample included 859 ASD cases from the ACC cohort, 1,336 ASD cases from the AGRE cohort, and 2,519 unaffected controls (1,409 ACC discovery controls and 1,110 AGRE replication controls). All CNVs, except 16p11.2, AUTS2, NLGN3 and SHANK3, were experimentally validated in the ACC cohort. Regions listed represent the optimal overlap of cases and significance with respect to controls, as described in the Methods and Supplementary Fig. 5, upper panel. ‘Inh’ column lists the inheritance pattern of each CNV from parents to cases in the format <inherited from mother>:<inherited from father>:<denovo>. Pedigrees provided in Supplementary Fig. 9. The percentage of inheritance is listed in parenthesis next to these three values. Note that parents were not available for all cases.